SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,891.60 -343.86
( -0.45%)

Global Indices

Nasdaq

53,360.44 -120.34
(-0.23%)

Dow Jones

7,713.14 -52.92
(-0.68%)

Hang Seng

67,388.40 -1,831.85
(-2.65%)

Nikkei 225

10,735.70 15.40
(0.14%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9559391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

148.49

98533.48

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.68

Back

dr reddys laboratories ltd

Dr Reddy's Laboratories consolidated net profit declines 68.67% in the June 2026 quarter

Jul 22,2026

Net profit of Dr Reddy's Laboratories declined 68.67% to Rs 444.30 crore in the quarter ended June 2026 as against Rs 1418.10 crore during the previous quarter ended June 2025. Sales declined 5.56% to Rs 8070.50 crore in the quarter ended June 2026 as against Rs 8545.20 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8070.50	8545.20	-6
OPM %	10.65	25.44	-
PBDT	1089.90	2381.10	-54
PBT	553.30	1905.00	-71
NP	444.30	1418.10	-69

76,891.60 -343.86 ( -0.45%)

53,360.44 -120.34 (-0.23%)

7,713.14 -52.92 (-0.68%)

67,388.40 -1,831.85 (-2.65%)

10,735.70 15.40 (0.14%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)